In 2008, the FDA reported in a safety newsletter that "Safety reviews of [TNF-alpha] antagonists, infliximab [Remicade, Centocor Inc], etanercept [Enbrel, Manufactured by Immunex Corporation; marketed by Amgen and Wyeth Pharmaceuticals], and adalimumab [Humira, Abbott] identified rare cases of serious skin reactions, including erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), associated with the use of these biological products," the newsletter states. "The product labeling for infliximab has been updated to describe postmarketing reports of serious skin reactions. [The] FDA is continuing to analyze what, if any, revisions to product labeling are needed for etanercept and adalimumab."
We have had several members that have developed severe skin breakouts while on Remicade or Humira. I'll give you the link to the entire article so you can share it with your doctor in case you need to see a dermatologist.
http://www.medscape.com/viewarticle/571633